{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:23:32Z","timestamp":1794353012156,"version":"4.9.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02103-5","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T15:01:57Z","timestamp":1721228517000},"page":"1125-1142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Biochanin A Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Modulating the NF-\u03baB and MAPK Signaling Pathways"],"prefix":"10.1007","volume":"48","author":[{"given":"Komal Paresh","family":"Walvekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya Krishna","family":"Tirunavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhisheik Chowdary","family":"Eedara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusudhana","family":"Kuncha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"B.R.Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishna","family":"Sistla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Balaji","family":"Andugulapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabarinadh","family":"Chilaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"2103_CR1","doi-asserted-by":"crossref","unstructured":"Raharja A, Mahil SK, and Barker JN. 2021. Psoriasis: a brief overview. Clinical Medicine (Lond) 21(3): 170\u2013173.","DOI":"10.7861\/clinmed.2021-0257"},{"issue":"2","key":"2103_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/annrheumdis-2018-214065","volume":"78","author":"P Sewerin","year":"2019","unstructured":"Sewerin, P., et al. 2019. Prevalence and incidence of psoriasis and psoriatic arthritis. Annals of the Rheumatic Diseases 78 (2): 286\u2013287.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"2103_CR3","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon, A., and K. Sch\u00e4kel. 2019. Psoriasis Pathogenesis and Treatment. Int J Mol Sci 20 (6): 1475.","journal-title":"Int J Mol Sci"},{"issue":"5s","key":"2103_CR4","first-page":"6","volume":"102","author":"JM Hugh","year":"2018","unstructured":"Hugh, J.M., and J.M. Weinberg. 2018. Update on the pathophysiology of psoriasis. Cutis 102 (5s): 6\u201312.","journal-title":"Cutis"},{"issue":"3","key":"2103_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF00561130","volume":"258","author":"AJ Francis","year":"1977","unstructured":"Francis, A.J., and R. Marks. 1977. Factors responsible for dermally induced epidermal hyperplasia. Archives of Dermatological Research 258 (3): 275\u201380.","journal-title":"Archives of Dermatological Research"},{"issue":"18","key":"2103_CR6","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMra041320","volume":"352","author":"MP Sch\u00f6n","year":"2005","unstructured":"Sch\u00f6n, M.P., and W.H. Boehncke. 2005. Psoriasis. New England Journal of Medicine 352 (18): 1899\u20131912.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"2103_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0167-5699(98)01381-4","volume":"20","author":"JD Bos","year":"1999","unstructured":"Bos, J.D., and M.A. De Rie. 1999. The pathogenesis of psoriasis: Immunological facts and speculations. Immunology Today 20 (1): 40\u201346.","journal-title":"Immunology Today"},{"issue":"4","key":"2103_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/cmi.2012.15","volume":"9","author":"Y Cai","year":"2012","unstructured":"Cai, Y., C. Fleming, and J. Yan. 2012. New insights of T cells in the pathogenesis of psoriasis. Cellular & Molecular Immunology 9 (4): 302\u2013309.","journal-title":"Cellular & Molecular Immunology"},{"key":"2103_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/PTT.S294173","volume":"11","author":"H Ben Abdallah","year":"2021","unstructured":"Ben Abdallah, H., and C. Johansen. 2021. Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics. Psoriasis: Targets and Therapy 11: 83\u201397.","journal-title":"Psoriasis: Targets and Therapy"},{"issue":"5","key":"2103_CR10","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jaci.2013.05.036","volume":"132","author":"PM Brunner","year":"2013","unstructured":"Brunner, P.M., et al. 2013. Infliximab induces downregulation of the IL-12\/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages. The Journal of Allergy and Clinical Immunology 132 (5): 1184-1193.e8.","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"12","key":"2103_CR11","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s13238-018-0505-z","volume":"9","author":"Y Hou","year":"2018","unstructured":"Hou, Y., et al. 2018. IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis. Protein & Cell 9 (12): 1027\u20131038.","journal-title":"Protein & Cell"},{"issue":"8","key":"2103_CR12","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1172\/JCI27180","volume":"116","author":"H Wang","year":"2006","unstructured":"Wang, H., et al. 2006. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. The Journal of Clinical Investigation 116 (8): 2105\u20132114.","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"2103_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/imm.12910","volume":"154","author":"SC Funes","year":"2018","unstructured":"Funes, S.C., et al. 2018. Implications of macrophage polarization in autoimmunity. Immunology 154 (2): 186\u2013195.","journal-title":"Immunology"},{"key":"2103_CR14","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","volume":"9","author":"C Albanesi","year":"2018","unstructured":"Albanesi, C., et al. 2018. The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis. Frontiers in Immunology 9: 1549.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"2103_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/13510002.2019.1658377","volume":"24","author":"F Xu","year":"2019","unstructured":"Xu, F., et al. 2019. Salidroside inhibits MAPK, NF-\u03baB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation. Redox Report 24 (1): 70\u201374.","journal-title":"Redox Report"},{"key":"2103_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.fct.2013.02.038","volume":"61","author":"E Corsini","year":"2013","unstructured":"Corsini, E., et al. 2013. Role of oxidative stress in chemical allergens induced skin cells activation. Food and Chemical Toxicology 61: 74\u201381.","journal-title":"Food and Chemical Toxicology"},{"issue":"2","key":"2103_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","volume":"69","author":"AM Goldminz","year":"2013","unstructured":"Goldminz, A.M., et al. 2013. NF-\u03baB: An essential transcription factor in psoriasis. Journal of Dermatological Science 69 (2): 89\u201394.","journal-title":"Journal of Dermatological Science"},{"issue":"6","key":"2103_CR18","doi-asserted-by":"publisher","first-page":"BSR20200471","DOI":"10.1042\/BSR20200471","volume":"40","author":"A Liu","year":"2020","unstructured":"Liu, A., et al. 2020. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-\u03baB\/MAPK pathway. Bioscience Reports 40 (6): BSR20200471.","journal-title":"Bioscience Reports"},{"key":"2103_CR19","doi-asserted-by":"publisher","first-page":"817526","DOI":"10.3389\/fphar.2022.817526","volume":"13","author":"L Tang","year":"2022","unstructured":"Tang, L., et al. 2022. Punicalagin Alleviates Psoriasis by Inhibiting NF-\u03baB-Mediated IL-1\u03b2 Transcription and Caspase-1-Regulated IL-1\u03b2 Secretion. Frontiers in Pharmacology 13: 817526.","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"2103_CR20","first-page":"82","volume":"15","author":"H Bakshi","year":"2020","unstructured":"Bakshi, H., et al. 2020. Treatment of Psoriasis: A Comprehensive Review of Entire Therapies. Current Drug Safety 15 (2): 82\u2013104.","journal-title":"Current Drug Safety"},{"issue":"10275","key":"2103_CR21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi, K., et al. 2021. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. The Lancet 397 (10275): 754\u2013766.","journal-title":"The Lancet"},{"issue":"12","key":"2103_CR22","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1517\/14712598.2015.1084284","volume":"15","author":"A Alunno","year":"2015","unstructured":"Alunno, A., et al. 2015. Targeting the IL-23\/IL-17 axis for the treatment of psoriasis and psoriatic arthritis. Expert Opinion on Biological Therapy 15 (12): 1727\u20131737.","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"2","key":"2103_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/ijms19020530","volume":"19","author":"MA Boutet","year":"2018","unstructured":"Boutet, M.A., et al. 2018. Role of the IL-23\/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints. International Journal of Molecular Sciences 19 (2): 530.","journal-title":"International Journal of Molecular Sciences"},{"key":"2103_CR24","doi-asserted-by":"publisher","first-page":"561018","DOI":"10.1155\/2012\/561018","volume":"2012","author":"L Uva","year":"2012","unstructured":"Uva, L., et al. 2012. Mechanisms of action of topical corticosteroids in psoriasis. International Journal of Endocrinology 2012: 561018.","journal-title":"International Journal of Endocrinology"},{"key":"2103_CR25","doi-asserted-by":"crossref","unstructured":"Haustein, U.F., and\u00a0\u00a0M. Rytter. 2000. Methotrexate in psoriasis: 26 years\u2019 experience with low\u2010dose long\u2010term treatment. Journal of the European Academy of Dermatology and Venereology\u00a014(5): 382\u2013388.","DOI":"10.1046\/j.1468-3083.2000.00058.x"},{"key":"2103_CR26","doi-asserted-by":"crossref","unstructured":"Koycheva, I.K., et al. 2023. Natural alternatives targeting psoriasis pathology and key signaling pathways: A focus on phytochemicals.\u00a0Phytochemistry Reviews, 1\u201327.","DOI":"10.1007\/s11101-023-09886-9"},{"issue":"4","key":"2103_CR27","first-page":"3421","volume":"20","author":"E Niculet","year":"2020","unstructured":"Niculet, E., et al. 2020. Influence of phytochemicals in induced psoriasis (Review). Experimental and Therapeutic Medicine 20 (4): 3421\u20133424.","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"12","key":"2103_CR28","doi-asserted-by":"publisher","first-page":"21138","DOI":"10.3390\/molecules201219753","volume":"20","author":"YJ Zhang","year":"2015","unstructured":"Zhang, Y.J., et al. 2015. Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases. Molecules 20 (12): 21138\u201321156.","journal-title":"Molecules"},{"key":"2103_CR29","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fphar.2019.01614","volume":"10","author":"AS Choudhari","year":"2019","unstructured":"Choudhari, A.S., et al. 2019. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. Frontiers in Pharmacology 10: 1614.","journal-title":"Frontiers in Pharmacology"},{"issue":"24","key":"2103_CR30","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.3390\/molecules25245932","volume":"25","author":"SA Shin","year":"2020","unstructured":"Shin, S.A., et al. 2020. Phytochemicals as anti-inflammatory agents in animal models of prevalent inflammatory diseases. Molecules 25 (24): 5932.","journal-title":"Molecules"},{"issue":"3","key":"2103_CR31","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/2156587216671392","volume":"22","author":"S Kumar","year":"2017","unstructured":"Kumar, S., G.J. Dobos, and T. Rampp. 2017. The Significance of Ayurvedic Medicinal Plants. Journal of Evidence-Based Complementary & Alternative Medicine 22 (3): 494\u2013501.","journal-title":"Journal of Evidence-Based Complementary & Alternative Medicine"},{"issue":"1","key":"2103_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31024\/ajpp.2018.4.1.1","volume":"4","author":"A Sundaresan","year":"2018","unstructured":"Sundaresan, A., T. Radhiga, and B. Deivasigamani. 2018. Biological Activity of Biochanin A: A Review. Asian Journal of Pharmacy and Pharmacology 4 (1): 1\u20135.","journal-title":"Asian Journal of Pharmacy and Pharmacology"},{"key":"2103_CR33","doi-asserted-by":"publisher","first-page":"153298","DOI":"10.1016\/j.phymed.2020.153298","volume":"78","author":"SB Andugulapati","year":"2020","unstructured":"Andugulapati, S.B., et al. 2020. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-\u03b2 mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems. Phytomedicine 78: 153298.","journal-title":"Phytomedicine"},{"issue":"12","key":"2103_CR34","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1111\/jocd.15883","volume":"22","author":"M Tan","year":"2023","unstructured":"Tan, M., et al. 2023. Centella triterpenes cream as a potential drug for the treatment of hypertrophic scar through inhibiting the phosphorylation of STAT3: A network pharmacology analysis and in vitro experiments. Journal of Cosmetic Dermatology 22 (12): 3511\u20133519.","journal-title":"Journal of Cosmetic Dermatology"},{"issue":"3","key":"2103_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10753-022-01780-4","volume":"46","author":"RSS Kotipalli","year":"2023","unstructured":"Kotipalli, R.S.S., et al. 2023. Sinigrin Attenuates the Dextran Sulfate Sodium-induced Colitis in Mice by Modulating the MAPK Pathway. Inflammation 46 (3): 787\u2013807.","journal-title":"Inflammation"},{"key":"2103_CR36","doi-asserted-by":"publisher","first-page":"175820","DOI":"10.1016\/j.ejphar.2023.175820","volume":"953","author":"TB Shaikh","year":"2023","unstructured":"Shaikh, T.B., et al. 2023. Dehydrozingerone alleviates pulmonary fibrosis via inhibition of inflammation and epithelial-mesenchymal transition by regulating the Wnt\/\u03b2-catenin pathway. European Journal of Pharmacology 953: 175820.","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"2103_CR37","doi-asserted-by":"publisher","first-page":"e0155013","DOI":"10.1371\/journal.pone.0155013","volume":"11","author":"SA Balaji","year":"2016","unstructured":"Balaji, S.A., et al. 2016. Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance. PLoS ONE 11 (5): e0155013.","journal-title":"PLoS ONE"},{"key":"2103_CR38","doi-asserted-by":"publisher","first-page":"122027","DOI":"10.1016\/j.lfs.2023.122027","volume":"330","author":"SK Tirunavalli","year":"2023","unstructured":"Tirunavalli, S.K., et al. 2023. Protective effect of \u03b2-glucan on Poly(I:C)-induced acute lung injury\/inflammation: Therapeutic implications of viral infections in the respiratory system. Life Sciences 330: 122027.","journal-title":"Life Sciences"},{"issue":"1","key":"2103_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13765-019-0455-z","volume":"62","author":"DH Choi","year":"2019","unstructured":"Choi, D.H., and H.S. Hwang. 2019. Anti-inflammation activity of brazilin in TNF-\u03b1 induced human psoriasis dermatitis skin model. Applied Biological Chemistry 62 (1): 46.","journal-title":"Applied Biological Chemistry"},{"issue":"4","key":"2103_CR40","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4103\/0019-5154.113948","volume":"58","author":"N Moorchung","year":"2013","unstructured":"Moorchung, N., et al. 2013. A Study of Various Histopathological Features and their Relevance in Pathogenesis of Psoriasis. Indian Journal of Dermatology 58 (4): 294\u2013298.","journal-title":"Indian Journal of Dermatology"},{"key":"2103_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.procbio.2022.10.029","volume":"123","author":"VK Jaina","year":"2022","unstructured":"Jaina, V.K., et al. 2022. Anti-cancer activity of Biochanin A against multiple myeloma by targeting the CD38 and cancer stem-like cells. Process Biochemistry 123: 11\u201326.","journal-title":"Process Biochemistry"},{"issue":"4","key":"2103_CR42","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/biof.1514","volume":"45","author":"F Liang","year":"2019","unstructured":"Liang, F., et al. 2019. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells. BioFactors 45 (4): 563\u2013574.","journal-title":"BioFactors"},{"key":"2103_CR43","doi-asserted-by":"publisher","first-page":"2249834","DOI":"10.1155\/2022\/2249834","volume":"2022","author":"MV Medovic","year":"2022","unstructured":"Medovic, M.V., et al. 2022. Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches. Oxidative Medicine and Cellular Longevity 2022: 2249834.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"2103_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2133.2004.06304.x","volume":"152","author":"C Johansen","year":"2005","unstructured":"Johansen, C., et al. 2005. The mitogen-activated protein kinases p38 and ERK1\/2 are increased in lesional psoriatic skin. British Journal of Dermatology 152 (1): 37\u201342.","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"2103_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/ijd.12050","volume":"53","author":"N Moorchung","year":"2014","unstructured":"Moorchung, N., et al. 2014. Role of NF-\u03baB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens. International Journal of Dermatology 53 (5): 570\u2013574.","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"2103_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0014-4827(03)00293-3","volume":"290","author":"S Holvoet","year":"2003","unstructured":"Holvoet, S., et al. 2003. The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes. Experimental Cell Research 290 (1): 108\u2013119.","journal-title":"Experimental Cell Research"},{"issue":"3","key":"2103_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/jcp.10435","volume":"198","author":"SK Moon","year":"2004","unstructured":"Moon, S.K., B.Y. Cha, and C.H. Kim. 2004. ERK1\/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway. Journal of Cellular Physiology 198 (3): 417\u2013427.","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"2103_CR48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/bbrc.1997.7064","volume":"237","author":"R Newton","year":"1997","unstructured":"Newton, R., et al. 1997. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochemical and Biophysical Research Communications 237 (1): 28\u201332.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2103_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2199-3-16","volume":"3","author":"B Kaltschmidt","year":"2002","unstructured":"Kaltschmidt, B., et al. 2002. Cyclooxygenase-2 is a neuronal target gene of NF-kappaB. BMC Molecular Biology 3: 16.","journal-title":"BMC Molecular Biology"},{"issue":"6","key":"2103_CR50","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/eji.202149706","volume":"52","author":"X Dai","year":"2022","unstructured":"Dai, X., and M. Murakami. 2022. EGFR ligands synergistically increase IL-17A-induced expression of psoriasis signature genes in human keratinocytes via I\u03baB\u03b6 and Bcl3. European Journal of Immunology 52 (6): 994\u20131005.","journal-title":"European Journal of Immunology"},{"issue":"4","key":"2103_CR51","doi-asserted-by":"publisher","first-page":"e12409","DOI":"10.15252\/emmm.202012409","volume":"13","author":"P Novoszel","year":"2021","unstructured":"Novoszel, P., et al. 2021. Psoriatic skin inflammation is promoted by c-Jun\/AP-1-dependent CCL2 and IL-23 expression in dendritic cells. EMBO Molecular Medicine 13 (4): e12409.","journal-title":"EMBO Molecular Medicine"},{"key":"2103_CR52","doi-asserted-by":"publisher","first-page":"604785","DOI":"10.3389\/fimmu.2020.604785","volume":"11","author":"A Le","year":"2020","unstructured":"Le, A., et al. 2020. JNK1 Signaling Downstream of the EGFR Pathway Contributes to Aldara(\u00ae)-Induced Skin Inflammation. Frontiers in Immunology 11: 604785.","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"2103_CR53","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1346-8138.14112","volume":"45","author":"K Nakajima","year":"2018","unstructured":"Nakajima, K., and S. Sano. 2018. Mouse models of psoriasis and their relevance. The Journal of Dermatology. 45 (3): 252\u2013263.","journal-title":"The Journal of Dermatology."},{"key":"2103_CR54","doi-asserted-by":"publisher","first-page":"106246","DOI":"10.1016\/j.phrs.2022.106246","volume":"180","author":"FB Felix","year":"2022","unstructured":"Felix, F.B., et al. 2022. Biochanin A as a modulator of the inflammatory response: An updated overview and therapeutic potential. Pharmacological Research 180: 106246.","journal-title":"Pharmacological Research"},{"key":"2103_CR55","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/B978-0-12-805417-8.00023-8","volume-title":"Immunity and Inflammation in Health and Disease","author":"M Bonesi","year":"2018","unstructured":"Bonesi, M., et al. 2018. Chapter 23 - Flavonoids in Treating Psoriasis. In Immunity and Inflammation in Health and Disease, ed. S. Chatterjee, W. Jungraithmayr, and D. Bagchi, 281\u2013294. Academic Press."},{"issue":"1","key":"2103_CR56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12860-021-00395-1","volume":"22","author":"M Wagner","year":"2021","unstructured":"Wagner, M., et al. 2021. Extracellular matrix alterations in the skin of patients affected by psoriasis. BMC Molecular and Cell Biology 22 (1): 55.","journal-title":"BMC Molecular and Cell Biology"},{"issue":"2","key":"2103_CR57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.matbio.2009.01.001","volume":"28","author":"TR Kyriakides","year":"2009","unstructured":"Kyriakides, T.R., et al. 2009. Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Matrix Biology 28 (2): 65\u201373.","journal-title":"Matrix Biology"},{"issue":"7","key":"2103_CR58","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/life11070599","volume":"11","author":"R Boz\u00f3","year":"2021","unstructured":"Boz\u00f3, R., and J. Danis. 2021. Stress-Related Regulation Is Abnormal in the Psoriatic Uninvolved Skin. Life. 11 (7): 599.","journal-title":"Life."},{"issue":"3","key":"2103_CR59","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jid.2020.07.030","volume":"141","author":"M Kelel","year":"2021","unstructured":"Kelel, M., et al. 2021. FUT8 Remodeling of EGFR Regulates Epidermal Keratinocyte Proliferation during Psoriasis Development. The Journal of Investigative Dermatology 141 (3): 512\u2013522.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"3","key":"2103_CR60","first-page":"319","volume":"48","author":"T Batinac","year":"2007","unstructured":"Batinac, T., et al. 2007. Expression of Bcl-2 family proteins in psoriasis. Croatian Medical Journal 48 (3): 319\u2013326.","journal-title":"Croatian Medical Journal"},{"issue":"5","key":"2103_CR61","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1365-4632.2007.03099.x","volume":"46","author":"M El-Domyati","year":"2007","unstructured":"El-Domyati, M., et al. 2007. Apoptosis, P53 and Bcl-2 expression in response to topical calcipotriol therapy for psoriasis. International Journal of Dermatology 46 (5): 468\u2013474.","journal-title":"International Journal of Dermatology"},{"key":"2103_CR62","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.intimp.2019.01.054","volume":"69","author":"A Wang","year":"2019","unstructured":"Wang, A., et al. 2019. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-\u03baB-dependent mechanism in keratinocytes. International Immunopharmacology 69: 270\u2013278.","journal-title":"International Immunopharmacology"},{"issue":"1","key":"2103_CR63","doi-asserted-by":"publisher","first-page":"18297","DOI":"10.1038\/s41598-021-97793-4","volume":"11","author":"K Boche\u0144ska","year":"2021","unstructured":"Boche\u0144ska, K., et al. 2021. Impact of isoflavone genistein on psoriasis in in vivo and in vitro investigations. Scientific Reports 11 (1): 18297.","journal-title":"Scientific Reports"},{"key":"2103_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.lfs.2017.04.019","volume":"180","author":"J Yu","year":"2017","unstructured":"Yu, J., et al. 2017. Paeoniflorin suppressed IL-22 via p38 MAPK pathway and exerts anti-psoriatic effect. Life Sciences 180: 17\u201322.","journal-title":"Life Sciences"},{"issue":"3","key":"2103_CR65","first-page":"3789","volume":"17","author":"J Yu","year":"2018","unstructured":"Yu, J., et al. 2018. Astilbin emulsion improves guinea pig lesions in a psoriasis-like model by suppressing IL-6 and IL-22 via p38 MAPK. Molecular Medicine Reports 17 (3): 3789\u20133796.","journal-title":"Molecular Medicine Reports"},{"issue":"15","key":"2103_CR66","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.3390\/molecules24152727","volume":"24","author":"C Mo","year":"2019","unstructured":"Mo, C., D. Shetti, and K. Wei. 2019. Erianin Inhibits Proliferation and Induces Apoptosis of HaCaT Cells via ROS-Mediated JNK\/c-Jun and AKT\/mTOR Signaling Pathways. Molecules 24 (15): 2727.","journal-title":"Molecules"},{"issue":"2","key":"2103_CR67","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jdermsci.2012.10.018","volume":"69","author":"L Chen","year":"2013","unstructured":"Chen, L., et al. 2013. c-Jun N-terminal kinase (JNK)-phospho-c-JUN (ser63\/73) pathway is essential for FOXP3 nuclear translocation in psoriasis. Journal of Dermatological Science 69 (2): 114\u2013121.","journal-title":"Journal of Dermatological Science"},{"key":"2103_CR68","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.intimp.2018.11.031","volume":"66","author":"X Huang","year":"2019","unstructured":"Huang, X., et al. 2019. ERK inhibitor JSI287 alleviates imiquimod-induced mice skin lesions by ERK\/IL-17 signaling pathway. International Immunopharmacology 66: 236\u2013241.","journal-title":"International Immunopharmacology"},{"issue":"10","key":"2103_CR69","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/exd.13745","volume":"27","author":"M Gao","year":"2018","unstructured":"Gao, M., and X. Si. 2018. Rapamycin ameliorates psoriasis by regulating the expression and methylation levels of tropomyosin via ERK1\/2 and mTOR pathways in vitro and in vivo. Experimental dermatology 27 (10): 1112\u20131119.","journal-title":"Experimental dermatology"},{"issue":"6","key":"2103_CR70","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1365-2133.2010.09706.x","volume":"162","author":"L Soegaard-Madsen","year":"2010","unstructured":"Soegaard-Madsen, L., et al. 2010. Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement. British Journal of Dermatology 162 (6): 1216\u20131223.","journal-title":"British Journal of Dermatology"},{"issue":"14","key":"2103_CR71","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.3390\/ijms21145164","volume":"21","author":"V Ramadass","year":"2020","unstructured":"Ramadass, V., T. Vaiyapuri, and V. Tergaonkar. 2020. Small Molecule NF-\u03baB Pathway Inhibitors in Clinic. International Journal of Molecular Sciences 21 (14): 5164.","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"2103_CR72","first-page":"2715","volume":"12","author":"A Drakos","year":"2022","unstructured":"Drakos, A., and R. Vender. 2022. A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians. 12 (12): 2715\u20132730.","journal-title":"A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians."},{"issue":"Suppl 1","key":"2103_CR73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40257-021-00655-y","volume":"23","author":"S Marrakchi","year":"2022","unstructured":"Marrakchi, S., and L. Puig. 2022. Pathophysiology of Generalized Pustular Psoriasis. American Journal of Clinical Dermatology 23 (Suppl 1): 13\u201319.","journal-title":"American Journal of Clinical Dermatology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02103-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02103-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02103-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T14:02:46Z","timestamp":1751983366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02103-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":73,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2103"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02103-5","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}